Interim / Quarterly Report • Dec 5, 2024
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
Half-Year Report for the six months ended 30 September 2024

| Company Overview | 1 |
|---|---|
| Financial Highlights for the six months | 2 |
| Summary of Performance | 3 |
| Strategic Report | |
| Chairman's Statement | 4 |
| Classification of Investments | 7 |
| Investment Portfolio | 8 |
| Financial Report | |
| Condensed Unaudited Statement of | |
| Comprehensive Income | 12 |
| Condensed Unaudited Statement of | |
| Financial Position | 14 |
| Condensed Unaudited Statement of | |
| Changes in Equity | 15 |
| Condensed Unaudited Cash Flow Statement | 16 |
| Notes to the Condensed Financial | |
| Statements (unaudited) | 17 |
| Statement of Principal Risks | |
| and Uncertainties | 24 |
| Statement of Directors' Responsibilities | |
| in Respect of the Half-Year Report | 25 |
| Alternative Performance Measures | 26 |
|---|---|
| Shareholder Information | 29 |
| How to Invest | 30 |
| Corporate Information | 32 |

This Half-Year report may contain forward-looking statements with respect to the financial condition, results of operations and business of the Company. Such statements involve risk and uncertainty because they relate to future events and circumstances that could cause actual results to differ materially from those expressed or implied by forward-looking statements. The forward-looking statements are based on the Directors' current view and on information known to them at the date of this report. Nothing should be construed as a profit forecast.
CT UK High Income Trust PLC (the "Company") is an investment trust and its shares are listed on the Official List of the Financial Conduct Authority and traded on the London Stock Exchange.
The purpose of the Company is to be a cost effective investment vehicle for investors seeking income and capital returns from a portfolio invested predominantly in UK equities.
The investment objective of the Company is to provide an attractive return to shareholders each year in the form of dividends and/or capital repayments, together with prospects for capital growth.
In pursuit of its objective, the Company invests predominantly in UK equities and equityrelated securities of companies across the market capitalisation spectrum.
The Company has two classes of shares: Ordinary shares and B shares. The rights of each class are identical, save in respect of the right to participate in distributions of dividends and capital. The net asset value attributable to each class of shares is the same.
Only Ordinary shares are entitled to dividends paid by the Company. B shares, instead of receiving dividends, receive a capital repayment at the same time as, and in an amount equal to, each dividend paid on the Ordinary shares.
Company registration number SC314671 Legal Entity Identifier: 213800B7D5D7RVZZPV45
| +6.8% | NAV total return(1) Net asset value total return per share for the six months was +6.8%, compared to the total return of the Benchmark(2) of +6.1% |
|---|---|
| +9.4% | Ordinary share price total return(1) Ordinary share price total return for the six months was +9.4% compared to the total return of the Benchmark(2) of +6.1% |
| +6.7% | B share price total return(1) B share price total return for the six months was +6.7% compared to the total return of the Benchmark(2) of +6.1% |
| 6.3% | Yield(1) on Ordinary Shares Distribution yield of 6.3% on Ordinary shares at 30 September 2024, compared to the yield on the FTSE All-Share Index of 3.6% |
| 6.5% | Yield(1) on B Shares Distribution yield of 6.5% on B shares at 30 September 2024, compared to the yield on the FTSE All-Share Index of 3.6% |
(1) Yield and total return – See Alternative Performance Measures on pages 27 and 28.
(2) Benchmark – FTSE All-Share Index.
Investors are reminded that the value of investments and any income from them may go down as well as up and they may not receive back the full amount invested. Tax benefits may vary as a result of statutory changes and their value will depend on individual circumstances.
| Total Return(1) | Six months to 30 September 2024 |
Year to 31 March 2024 |
|---|---|---|
| Net asset value per Ordinary share and B share | +6.8% | +11.8% |
| Ordinary share price | +9.4% | +10.2% |
| B share price | +6.7% | +5.5% |
| Benchmark(2) | +6.1% | +8.4% |
| 30 September 2024 |
31 March 2024 |
% Change | |
|---|---|---|---|
| Distributions | |||
| Yield(1) – Ordinary shares | 6.3% | 6.7% | |
| Yield(1) – B shares | 6.5% | 6.7% | |
| Capital | |||
| Net assets | £111.4m | £107.8m | +3.3 |
| Net asset value per Ordinary share and B share | 97.90p | 94.51p | +3.6 |
| FTSE All-Share Index | 4,511.00 | 4,338.05 | +4.0 |
| Discount(1) | |||
| Ordinary shares | -8.8% | -10.6% | |
| B shares | -12.2% | -11.6% | |
| Gearing(1) | |||
| Gearing | 12.8% | 12.5% |
(1) Total return, yield, discount and gearing – see Alternative Performance Measures on pages 26 to 28.
(2) Benchmark – see definition on page 2.
Sources: Columbia Threadneedle Investments and Refinitiv Eikon.

Andrew Watkins, Chairman
For the six months to 30 September 2024 the net asset value ("NAV") total return for both the Ordinary shares and B shares was +6.8%, which outperformed the +6.1% total return for the FTSE All-Share Index, the Company's benchmark index.
Equity markets globally have been positive in 2024 and the UK has joined in, albeit at a slower pace than other major markets, producing a total return of just over 6% in the six months to 30 September 2024. As is now the norm, market sectors have been volatile within this as they reacted to newsflow whether geo-political, macro-economic and on occasion even stock specific. Perhaps surprisingly, the continuing war in Ukraine, the conflict in the Middle East and the potential for this to expand into a wider regional war have had, in the main, limited impact on equity markets. The bigger focus once again has been on inflation and interest rates. When I wrote this statement a year ago, I noted that inflation had been stubborn but had begun to fall. This continued, possibly faster than many had anticipated, and stands now at around 2%. At last, the Bank has now begun to cut interest rates, rather belatedly in my view. They are still higher than most other major country, but the path is clear and equity markets responded positively.
The other major event in the last six months was of course the UK election and the resounding victory of the Labour party was at first seen very positively. Whatever the politics, investors were relieved at least, by the certainty that
the UK would be led by the same party and probably the same individuals for the next five years which, after the chaos of recent times, is indeed a big positive. Unfortunately, the positivity and enthusiasm ebbed away over the following months as the new government seemed to go out of its way to be increasingly negative on the inherited fiscal situation.
"With the possibility that both interest rates and inflation in the UK have peaked, the annual 6.8% yield (at 30 September 2023) from both the Company's Ordinary shares and B shares offers investors an attractive quarterly distribution"
Despite all of this, David Moss, our portfolio manager, does remain positive on the future of investing in UK equities. We will have a period of stable government – rather unusual in the context of our European trading partners – which, of itself, should encourage vital foreign direct investment to help our economy to grow. The anticipated cuts in interest rates will help reduce the cost of borrowing for all but particularly the cost of borrowing on mortgages. As I said a year ago, though, our portfolio manager continues to believe that while the cost of borrowing will continue to fall, we are in a regime more in common with the 1990s than the period post‑financial crisis and interest rates, wherever they settle, will remain positive in real terms, likely in the 3-4% range. He remains of the view this is a positive backdrop for borrowers and savers and the efficient allocation of capital.
Trading activity by the portfolio manager has been much less in the last six months to 30 September 2024, driven primarily by increasing the quality of the portfolio or the ability to generate sustainable and growing income.
Performance has been good during this period with the NAV total return out-performance of the benchmark coming from stock selection. Irish housebuilder Cairn Homes was one of the top contributors as the shares performed very strongly on the back of strong results and cash generation enabling them to continue returning cash to shareholders through an ongoing share buyback and growing dividend. Likewise, NatWest has delivered much better than expected results, despite the weak UK economic backdrop, which has enabled them to increase the dividend and continue to buy back shares from the government. In contrast, UK brickmaker Ibstock has delivered fairly weak results hurt by levels of UK housebuilding below 2009. They have continued to invest through this period leaving them very well positioned for the recovery which the Investment Manager is highly confident will come, as the UK continues to have a clear shortage of housing and increasing this is a very clear policy of the new Labour government.
Over the six month period, the discount to NAV at which the Company's Ordinary shares traded, narrowed from -10.6% to -8.8% at 30 September 2024 and consequently, the Ordinary share price total return for the period was +9.4%. The discount of the B shares to NAV widened slightly from -11.6% to -12.2% at the period end, thus generating a B share price total return of +6.7% for the period under review.
During the period, 250,000 B shares were bought back for treasury at an average discount of approximately 12% to the prevailing NAV. No Ordinary shares were bought back in the period under review. It continues to be the Board's strategy to buy back shares in line with the Company's stated policy, which helps to enhance the NAV per share for continuing shareholders,
especially if a mismatch of demand and supply causes the discount to widen.
In the period under review, your Company's revenue earnings per share has risen by 14.7% from 2.31p per share to 2.65p per share in comparison to the six months to 30 September 2023.
As I have previously stated, it is a key objective of the Board and Investment Manager to return to a covered dividend and rebuild the revenue reserve. Now that the changes made by the portfolio manager over the last year are coming to fruition, we believe the Company's revenue position at the half-year stage is in a much-improved position.
In the absence of unforeseen circumstances, it is the Board's current intention that the aggregate dividend and capital repayment for the current financial year to 31 March 2025 will be at least 5.62p per Ordinary share and B share respectively. Three quarterly interim dividends and capital repayments have so far been declared, each of 1.35p per share. At 30 September 2024, this aggregate distribution represented a yield of 6.3% and 6.5% on the Ordinary share price and B share price respectively, as compared with the yield on the FTSE All-Share Index of 3.6%.
At 30 September 2024, the Company had fully drawn down its £15 million revolving credit facility ("RCF") with The Royal Bank of Scotland International Limited. This facility provides flexibility for the Board and Investment Manager to utilise borrowing when investment opportunities arise or, conversely, reduce borrowing dependent on market conditions and outlook.
I talked earlier about the portfolio manager's positive view on investing in UK equities and in the context of this and looking forward, I must mention the UK budget. There had been a lot of leaks and even more speculation on its content but we have finally now seen the first budget from Rachel Reeves, the Chancellor of this new Labour government. The initial judgement from investors was positive with bond yields falling and domestic UK shares rising. Unfortunately, this lasted only until we saw the detailed numbers as the Office for Budget Responsibility revised up borrowing numbers and revised down growth. As investors digested this information and the sheer amount of debt the government intends to issue, sentiment turned more negative with bond yields rising sharply and shares falling. Even if this looks like a classic left-wing tactic of tax and spend, investment in UK infrastructure and housing is desperately needed. Businesses at least now know the rules under which they have to operate and the ultimate impact remains to be seen.
We probably all have a view on the pros and cons of borrowing more to invest and raising taxes but I think arguments will persist for some time as to whether pre-election promises have been broken and the right taxes have been raised. Whilst I think this debate will rumble on, the fact that we will have a period of stable government intending to invest more has to be beneficial for the long-term future of the country, helpful for economic growth and positive for those businesses that are exposed to infrastructure and housing in particular.
Without acknowledging it, this new Labour Government has actually inherited one of the fastest growing European economies and with fiscal clarity now here and interest rates still likely to fall further, our portfolio manager remains constructive on the UK and positive on UK domestic companies where dividends and valuations remain very attractive.
The landslide election victory by President-elect Trump in America defied prediction but is being taken particularly well by equity markets. His pre-election rhetoric is yet to be tested but, as the UK's largest single-country trading partner, we should take the early signs as encouraging. We shall see.
As ever, your support of this Company is very much appreciated.
28 November 2024
Source: BMO GAM
The following table shows, at 30 September 2024, the percentage weightings by industry classification benchmark ('ICB') industry of the investment portfolio in comparison to the FTSE All-Share Index.
| % of | % FTSE | |
|---|---|---|
| Total | All-Share | |
| ICB Industry | Investments | Index |
| Financials | 25.4 | 24.7 |
| Consumer Discretionary | 16.9 | 11.3 |
| Industrials | 11.8 | 12.1 |
| Health Care | 10.0 | 11.7 |
| Consumer Staples | 9.0 | 14.6 |
| Energy | 7.2 | 9.3 |
| Utilities | 6.7 | 4.0 |
| Basic Materials | 5.6 | 6.9 |
| Real Estate | 4.6 | 2.8 |
| Technology | 2.8 | 1.3 |
| Telecommunications | – | 1.3 |
| Total | 100.0 | 100.0 |

| Market Value 30 September 2024 |
% of Total |
|
|---|---|---|
| Company (ICB Industry – Sector) | £'000 | Investments |
| Shell (Energy – Oil, Gas & Coal) A leading international oil exploration, production and marketing group. Historically, Shell and its peers struggled to generate consistently good returns on capital, but the combination of a higher oil price and much greater capital discipline is driving higher returns and very strong cash generation. |
9,050 | 7.2 |
| Astrazeneca (Health Care – Pharmaceuticals & Biotechnology) | ||
| AstraZeneca is a major international pharmaceutical company which has consistently been one of the most innovative companies in the UK. Its pipeline of new drugs is proving successful and producing strong growth now, with more potential further out. |
7,933 | 6.3 |
| HSBC (Financials – Banks) | ||
| The Hong Kong based UK listed bank is one of the largest global financial institutions with very strong positions in Hong Kong, the UK and Global Wealth Management. Over the long run we expect good growth from the Chinese market where it has the strongest position amongst Western listed banks. |
7,567 | 6.0 |
| Rio Tinto (Basic Materials – Industrial Metals & Mining) Rio Tinto is a diversified international mining company with very strong positions in iron ore and aluminium and has been investing heavily in copper where demand should grow over many years due to the |
||
| demands from electrification. | 7,004 | 5.6 |
| Unilever (Consumer Staples – Personal Care, Drug & Grocery Stores) | ||
| Unilever is one of the world's largest personal care businesses with | ||
| brands such as Dove, Persil and Lynx. Under a new CEO, the company has begun to reinvest in its brands through research and development |
||
| and marketing and is starting to see the benefits in better volume | ||
| growth, well ahead of its competitors. | 4,992 | 4.0 |
| Market Value 30 September 2024 |
% of Total |
|
|---|---|---|
| Company (ICB Industry – Sector) | £'000 | Investments |
| Phoenix Group Holdings (Financials – Life Insurance) Phoenix Group is the UK's largest long-term savings and retirement business and offer a range of products across their market-leading pensions, savings and life insurance brands. Phoenix consistently pays a high and growing dividend. |
4,893 | 3.9 |
| GSK (Health Care – Pharmaceuticals & Biotechnology) GSK is a global manufacturer and marketer of pharmaceutical products. Post the spin-off of the over-the-counter healthcare business GSK is a pure play pharmaceutical company, with strong positions in areas such as vaccines and HIV treatment, and is starting to see a return in growth from its R&D investment. |
4,542 | 3.6 |
| Legal & General Group (Financials – Life Insurance) Legal & General is one of the UK's leading financial services groups. The market leader in the pension buy out market in the UK, this market is expected to provide strong growth for several years. Despite this growth, Legal & General pays out a high dividend to shareholders. |
4,515 | 3.6 |
| NatWest Group (Financials – Banks) NatWest is one of the foremost UK financial institutions with leading positions in all segments. The bank is very well capitalised which is enabling it to make significant returns to shareholders. |
4,248 | 3.4 |
| M&G (Financials – Investment Banking & Brokerage Services) M&G is a UK asset manager and owner of the iconic UK insurance company Prudential. The business is very attractively valued paying an almost 10% dividend yield and has, we believe, good long term growth potential in the M&G asset management business and the Prufund product range. |
3,886 | 3.1 |
| Ten Largest Investments | 58,630 | 46.7 |
| Market Value | |||
|---|---|---|---|
| 30 September | % of | ||
| 2024 | Total | ||
| Company | ICB Industry – Sector | £'000 | Investments |
| Imperial Brands | Consumer Staples – Tobacco | 3,655 | 2.9 |
| Smurfit Westrock | Industrials – General Industrials | 3,505 | 2.8 |
| Rolls Royce | Industrials – Aerospace & Defense | 3,489 | 2.8 |
| OSB Group | Financials – Finance & Credit Services | 3,382 | 2.7 |
| Compass Group | Consumer Discretionary – Consumer Services | 3,374 | 2.7 |
| RELX | Consumer Discretionary – Media | 3,198 | 2.5 |
| Supermarket Income REIT |
Real Estate – Real Estate Investment Trusts | 3,144 | 2.5 |
| National Grid | Utilities – Gas, Water & Multi-utilities | 3,106 | 2.5 |
| Taylor Wimpey | Consumer Discretionary – Household Goods & Home Construction |
2,847 | 2.3 |
| SSE | Utilities – Electricity | 2,720 | 2.1 |
| Twenty Largest | |||
| Investments | 91,050 | 72.5 | |
| British American Tobacco |
Consumer Staples – Tobacco | 2,683 | 2.1 |
| Persimmon | Consumer Discretionary – Household Goods & Home Construction |
2,634 | 2.1 |
| Londonmetric Property | Real Estate – Real Estate Investment Trusts | 2,630 | 2.1 |
| WPP | Consumer Discretionary – Media | 2,589 | 2.1 |
| Pennon Group | Utilities – Gas, Water & Multi-utilities | 2,550 | 2.0 |
| Cairn Homes | Consumer Discretionary – Household Goods & Home Construction |
2,480 | 2.0 |
| Dunelm Group | Consumer Discretionary – Retailers | 2,056 | 1.6 |
| Intermediate Capital | Financials – Investment Banking & Brokerage Services |
1,974 | 1.6 |
| Ibstock | Industrials – Construction & Materials | 1,952 | 1.6 |
| Pearson | Consumer Discretionary – Media | 1,951 | 1.5 |
| Thirty Largest Investments |
114,549 | 91.2 |
| Market Value 30 September |
% of | ||
|---|---|---|---|
| Company | ICB Industry – Sector | 2024 £'000 |
Total Investments |
| Breedon | Industrials – Construction & Materials | 1,659 | 1.3 |
| Ashtead Group | Industrials – Industrial Transportation | 1,468 | 1.2 |
| Rotork | Industrials – Electronic & Electrical Equipment | 1,425 | 1.1 |
| Burford Capital | Financials – Investment Banking & Brokerage Services |
1,403 | 1.1 |
| Sage Group | Technology – Software & Computer Services | 1,348 | 1.1 |
| Schneider Electric | Industrials – Electronic & Electrical Equipment | 1,304 | 1.1 |
| ASM International | Technology – Technology Hardware & Equipment |
1,174 | 0.9 |
| SAP SE | Technology – Software & Computer Services | 1,046 | 0.8 |
| Investors Securities Company Limited |
N/A (subsidiary undertaking) | 250 | 0.2 |
| Total Investments | 125,626 | 100.0 |
| Six months to 30 September 2024 | Six months to 30 September 2023 | Year to 31 March 2024* | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Notes | Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
|
| Gains/(losses) on investments held at fair value | – | 4,831 | 4,831 | – | (3,694) | (3,694) | – | 7,674 | |
| Exchange (losses)/gains | – | (4) | (4) | – | 15 | 15 | 1 | 9 | |
| 2 | Income | 3,529 | – | 3,529 | 3,141 | – | 3,141 | 5,603 | – |
| 3 | Investment management fee | (100) | (233) | (333) | (91) | (213) | (304) | (186) | (435) |
| Other expenses | (222) | – | (222) | (223) | – | (223) | (518) | – | |
| Profit/(loss) before finance costs and taxation | 3,207 | 4,594 | 7,801 | 2,827 | (3,892) | (1,065) | 4,900 | 7,248 | |
| Net finance costs | |||||||||
| Interest on bank loans | (144) | (336) | (480) | (122) | (283) | (405) | (269) | (627) | |
| Total finance costs | (144) | (336) | (480) | (122) | (283) | (405) | (269) | (627) | |
| Profit/(loss) before tax | 3,063 | 4,258 | 7,321 | 2,705 | (4,175) | (1,470) | 4,631 | 6,621 | |
| 4 | Tax on ordinary activities | (46) | – | (46) | (38) | – | (38) | (30) | – |
| Profit/(loss) for the period | 3,017 | 4,258 | 7,275 | 2,667 | (4,175) | (1,508) | 4,601 | 6,621 | |
| Total comprehensive income for the period | 3,017 | 4,258 | 7,275 | 2,667 | (4,175) | (1,508) | 4,601 | 6,621 | |
| 5 | Earnings per share | 2.65p | 3.73p | 6.38p | 2.31p | (3.62)p | (1.31)p | 4.01p | 5.77p |
| Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Gains/(losses) on investments held at fair value | – | 4,831 | 4,831 | – (3,694) |
(3,694) | – | 7,674 | 7,674 | ||
| Exchange (losses)/gains | – | (4) | (4) | – 15 |
15 | 1 | 9 | 10 | ||
| 2 | Income | 3,529 | – | 3,529 | 3,141 | – | 3,141 | 5,603 | – | 5,603 |
| 3 | Investment management fee | (100) | (233) | (333) | (91) | (213) | (304) | (186) | (435) | (621) |
| Other expenses | (222) | – | (222) | (223) | – | (223) | (518) | – | (518) | |
| Profit/(loss) before finance costs and taxation | 3,207 | 4,594 | 7,801 | 2,827 | (3,892) | (1,065) | 4,900 | 7,248 | 12,148 | |
| Net finance costs | ||||||||||
| Interest on bank loans | (144) | (336) | (480) | (122) | (283) | (405) | (269) | (627) | (896) | |
| Total finance costs | (144) | (336) | (480) | (122) | (283) | (405) | (269) | (627) | (896) | |
| Profit/(loss) before tax | 3,063 | 4,258 | 7,321 | 2,705 | (4,175) | (1,470) | 4,631 | 6,621 | 11,252 | |
| 4 | Tax on ordinary activities | (46) | – | (46) | (38) | – | (38) | (30) | – | (30) |
| Profit/(loss) for the period | 3,017 | 4,258 | 7,275 | 2,667 | (4,175) | (1,508) | 4,601 | 6,621 | 11,222 | |
| Total comprehensive income for the period | 3,017 | 4,258 | 7,275 | 2,667 | (4,175) | (1,508) | 4,601 | 6,621 | 11,222 | |
| 5 | Earnings per share | 2.65p | 3.73p | 6.38p | 2.31p | (3.62)p | (1.31)p | 4.01p | 5.77p | 9.78p |
The total column of this statement represents the Company's Profit and Loss Account. The supplementary revenue return and capital return columns are both prepared under guidance published by the Association of Investment Companies.
All revenue and capital items in the above statement derive from continuing operations.
All of the profit and comprehensive income for the period is attributable to the owners of the Company.
The accompanying notes on pages 17 to 23 are an integral part of these condensed financial statements.
| Notes | As at 30 September 2024 £'000 |
As at 30 September 2023 £'000 |
As at 31 March 2024* £'000 |
|
|---|---|---|---|---|
| Non-current assets | ||||
| 9 | Investments held at fair value through profit or loss | 125,626 | 112,301 | 121,267 |
| 125,626 | 112,301 | 121,267 | ||
| Current assets | ||||
| 10 | Receivables | 513 | 970 | 1,203 |
| Cash and cash equivalents | 787 | 282 | 1,086 | |
| 1,300 | 1,252 | 2,289 | ||
| Total assets | 126,926 | 113,553 | 123,556 | |
| Current liabilities | ||||
| 11 | Payables | (534) | (506) | (790) |
| 12 | Bank loans | (15,000) | (15,000) | (15,000) |
| Total liabilities | (15,534) | (15,506) | (15,790) | |
| Net assets | 111,392 | 98,047 | 107,766 | |
| Capital and reserves | ||||
| 13 | Share capital | 134 | 134 | 134 |
| Share premium | 153 | 153 | 153 | |
| Capital redemption reserve | 5 | 5 | 5 | |
| Buy back reserve | 78,806 | 79,022 | 79,022 | |
| Special capital reserve | 7,395 | 9,131 | 8,320 | |
| Capital reserves | 20,702 | 5,648 | 16,444 | |
| Revenue reserve | 4,197 | 3,954 | 3,688 | |
| Equity shareholders' funds | 111,392 | 98,047 | 107,766 | |
| 14 | Net asset value per Ordinary share | 97.90p | 85.98p | 94.51p |
| 14 | Net asset value per B share | 97.90p | 85.98p | 94.51p |
Approved by the Board, and authorised for issue, on 28 November 2024 and signed on its behalf by:
| Notes | Share Capital £'000 |
Share Premium £'000 |
Capital Redemption Reserve £'000 |
Buy back Reserve £'000 |
Special Capital Reserve £'000 |
Capital Reserves £'000 |
Revenue Reserve £'000 |
Total £'000 |
|
|---|---|---|---|---|---|---|---|---|---|
| Balance as at 1 April 2024 | 134 | 153 | 5 | 79,022 | 8,320 | 16,444 | 3,688 | 107,766 | |
| Profit for the period | – | – | – | – | – | 4,258 | 3,017 | 7,275 | |
| 13 | Shares bought back for treasury | – | – | – | (216) | – | – | – | (216) |
| 8 | Dividends paid on Ordinary shares | – | – | – | – | – | – | (2,508) | (2,508) |
| 8 | Capital returns paid on B shares | – | – | – | – | (925) | – | – | (925) |
| Balance as at | |||||||||
| 30 September 2024 | 134 | 153 | 5 | 78,806 | 7,395 | 20,702 | 4,197 | 111,392 |
For the six months to 30 September 2023
| Notes | Share Capital £'000 |
Share Premium £'000 |
Capital Redemption Reserve £'000 |
Buy back Reserve £'000 |
Special Capital Reserve £'000 |
Capital Reserves £'000 |
Revenue Reserve £'000 |
Total £'000 |
|
|---|---|---|---|---|---|---|---|---|---|
| Balance as at 1 April 2023 | 134 | 153 | 5 | 80,315 | 10,012 | 9,823 | 3,729 | 104,171 | |
| (Loss)/profit for the period | – | – | – | – | – | (4,175) | 2,667 | (1,508) | |
| Shares bought back for treasury | – | – | – | (1,293) | – | – | – | (1,293) | |
| 8 | Dividends paid on Ordinary shares | – | – | – | – | – | – | (2,442) | (2,442) |
| 8 | Capital returns paid on B shares | – | – | – | – | (881) | – | – | (881) |
| Balance as at | |||||||||
| 30 September 2023 | 134 | 153 | 5 | 79,022 | 9,131 | 5,648 | 3,954 | 98,047 |
For the year to 31 March 2024*
| Notes | Share Capital £'000 |
Share Premium £'000 |
Capital Redemption Reserve £'000 |
Buy back Reserve £'000 |
Special Capital Reserve £'000 |
Capital Reserves £'000 |
Revenue Reserve £'000 |
Total £'000 |
|
|---|---|---|---|---|---|---|---|---|---|
| Balance as at 1 April 2023 | 134 | 153 | 5 | 80,315 | 10,012 | 9,823 | 3,729 | 104,171 | |
| Profit for the year | – | – | – | – | – | 6,621 | 4,601 | 11,222 | |
| Shares bought back for treasury | – | – | – | (1,293) | – | – | – | (1,293) | |
| 8 | Dividends paid on Ordinary shares | – | – | – | – | – | – | (4,642) | (4,642) |
| 8 | Capital returns paid on B shares | – | – | – | – | (1,692) | – | – | (1,692) |
| Balance as at | |||||||||
| 31 March 2024 | 134 | 153 | 5 | 79,022 | 8,320 | 16,444 | 3,688 | 107,766 |
| Six months to 30 September 2024 £'000 |
Six months to 30 September 2023 £'000 |
Year to 31 March 2024* £'000 |
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Profit/(loss) before tax | 7,321 | (1,470) | 11,252 |
| Adjustments for: | |||
| (Gains)/losses on investments held at fair value | |||
| through profit or loss | (4,831) | 3,694 | (7,674) |
| Exchange losses/(gains) | 4 | (15) | (10) |
| Interest income | (34) | (36) | (84) |
| Interest received | 34 | 36 | 84 |
| Dividend income | (3,495) | (3,105) | (5,519) |
| Dividend income received | 4,140 | 3,576 | 5,727 |
| Decrease/(increase) in receivables | 9 | (2) | 1 |
| (Decrease)/increase in payables | (37) | (22) | 45 |
| Finance costs | 480 | 406 | 896 |
| Overseas tax suffered | (20) | (97) | (69) |
| Cash flows from operating activities | 3,571 | 2,965 | 4,649 |
| Cash flows from investing activities | |||
| Purchases of investments | (30,519) | (37,247) | (62,065) |
| Sales of investments | 30,782 | 34,270 | 61,699 |
| Cash flows from investing activities | 263 | (2,977) | (366) |
| Cash flows from financing activities | |||
| Dividends paid on Ordinary shares | (2,508) | (2,442) | (4,642) |
| Capital returns paid on B shares | (925) | (881) | (1,692) |
| Interest on bank loans | (480) | (393) | (868) |
| Shares purchased for treasury | (216) | (1,293) | (1,293) |
| Drawdown of bank loans | – | 3,000 | 3,000 |
| Cash flows from financing activities | (4,129) | (2,009) | (5,495) |
| Net decrease in cash and cash equivalents | (295) | (2,021) | (1,212) |
| Effect of movement in foreign exchange | (4) | 15 | 10 |
| Opening net cash and cash equivalents | 1,086 | 2,288 | 2,288 |
| Closing cash and cash equivalents | 787 | 282 | 1,086 |
| Represented by: | |||
| Cash at bank | 47 | 73 | 176 |
| Short term deposits | 740 | 209 | 910 |
| 787 | 282 | 1,086 |
The condensed unaudited financial statements have been prepared on a going concern basis and in accordance with UK-adopted International Accounting Standard 34 "Interim Financial Reporting" and the accounting policies set out in the statutory financial statements of the Company for the year ended 31 March 2024. Where presentational guidance set out in the Statement of Recommended Practice ("SORP") for investment trusts issued by the Association of Investment Companies is consistent with the requirements of UK-adopted International Accounting Standards, the Directors have sought to prepare the condensed financial statements on a basis compliant with the recommendations of the SORP. The condensed financial statements do not include all of the information required for full annual financial statements and should be read in conjunction with the financial statements of the Company for the year ended 31 March 2024, which were prepared under UK-adopted International Accounting Standards.
| 30 September | 30 September | 31 March | |
|---|---|---|---|
| 2024 | 2023 | 2024 | |
| Income comprises: | £'000 | £'000 | £'000 |
| UK dividend income | 2,773 | 2,575 | 4,653 |
| UK dividend income – special dividends | – | – | 46 |
| Overseas dividend income | 552 | 464 | 632 |
| Overseas dividend income – special dividends | – | 25 | 25 |
| Property income distributions | 170 | 41 | 163 |
| 3,495 | 3,105 | 5,519 | |
| Other income | |||
| Interest on cash and cash equivalents | 34 | 36 | 84 |
| 3,529 | 3,141 | 5,603 |
| Six months to | Six months to | Year to | ||
|---|---|---|---|---|
| Payment | 30 September 2024 |
30 September 2023 |
31 March 2024 |
|
| Dividends | date | £'000 | £'000 | £'000 |
| In respect of the previous period: | ||||
| Fourth interim dividend at 1.66p (2023: 1.55p) per Ordinary share |
3-May-24 | 1,383 | 1,319 | 1,319 |
| In respect of the period under review: | ||||
| First interim dividend at 1.35p (2024: 1.32p) per Ordinary share |
2-Aug-24 | 1,125 | 1,123 | 1,123 |
| Second interim dividend (2024: 1.32p) per Ordinary share |
– | - | 1,100 | |
| Third interim dividend (2024: 1.32p) per Ordinary share |
– | - | 1,100 | |
| 2,508 | 2,442 | 4,642 |
A second interim dividend for the year to 31 March 2025, of 1.35p per Ordinary share, was paid on 1 November 2024 to Ordinary shareholders on the register on 4 October 2024.
| Capital repayments | Payment date |
Six months to 30 September 2024 £'000 |
Six months to 30 September 2023 £'000 |
Year to 31 March 2024 £'000 |
|---|---|---|---|---|
| In respect of the previous period: | ||||
| Fourth capital repayment at 1.66p (2023: 1.55p) per B share |
3-May-24 | 510 | 476 | 476 |
| In respect of the period under review: | ||||
| First capital repayment at 1.35p (2024: 1.32p) per B share |
2-Aug-24 | 415 | 405 | 405 |
| Second capital repayment (2024: 1.32p) per B share | – | - | 406 | |
| Third capital repayment (2024: 1.32p) per B share | – | - | 405 | |
| 925 | 881 | 1,692 |
A second capital repayment for the year to 31 March 2025, of 1.35p per B share, was paid on 1 November 2024 to B shareholders on the register on 4 October 2024.
Although the above referenced payments on 1 November 2024 relate to the period ended 30 September 2024, under UK-adopted International Accounting Standards they will be accounted for in the six months to 31 March 2025, being the period during which they are paid.
| Listed/ Quoted (Level 1) |
Subsidiary/ Unlisted (Level 3) |
Total | |
|---|---|---|---|
| £'000 | £'000 | £'000 | |
| Cost brought forward Gains brought forward |
105,822 15,195 |
250 – |
106,072 15,195 |
| Fair value of investments at 31 March 2024 | 121,017 | 250 | 121,267 |
| Movement in the period: | |||
| Purchases at cost | 30,310 | – | 30,310 |
| Sales proceeds | (30,782) | – | (30,782) |
| Gains on investments sold in the period | 5,227 | – | 5,227 |
| Losses on investments held at 30 September 2024 | (396) | – | (396) |
| Fair value of investments at 30 September 2024 | 125,376 | 250 | 125,626 |
| Cost at 30 September 2024 | 110,577 | 250 | 110,827 |
| Gains at 30 September 2024 | 14,799 | – | 14,799 |
| Fair value of investments at 30 September 2024 | 125,376 | 250 | 125,626 |
Accounting standards recognise a hierarchy of fair value measurements for financial instruments which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The classification of financial instruments depends on the lowest significant applicable input, as follows:
There were no transfers between levels of the fair value hierarchy during the six months ended 30 September 2024.
| 30 September 2024 £'000 |
30 September 2023 £'000 |
31 March 2024 £'000 |
|
|---|---|---|---|
| Income receivable from shares and securities | 322 | 704 | 967 |
| Withholding tax recoverable | 153 | 199 | 179 |
| Sundry debtors and prepayments | 38 67 |
57 | |
| 513 | 970 | 1,203 |
| 30 September 2024 £'000 |
30 September 2023 £'000 |
31 March 2024 £'000 |
|
|---|---|---|---|
| Loan from subsidiary undertaking repayable on demand | 250 | 250 | 250 |
| Investment management fee payable to the investment manager | 168 | 148 | 161 |
| Amounts due to brokers in settlement of purchase of investments | – | – | 209 |
| Loan interest | – | 2 | 10 |
| Accrued expenses | 116 | 106 | 160 |
| 534 | 506 | 790 |
The Company has an unsecured revolving credit facility ('RCF') with The Royal Bank of Scotland International Limited for £15 million which is available until 28 September 2025. At 30 September 2024, £15 million was drawn down (30 September 2023: £15 million; 31 March 2024: £15 million).
The loan agreement contains certain financial covenants with which the Company must comply. These include a financial covenant with respect to the ratio of the Adjusted Portfolio Value (as defined in the loan agreement) to the level of debt and also that the Adjusted Portfolio Value does not fall below £50 million. The Company complied with the required financial covenants throughout the period since drawdown.
| Listed | Held in Treasury | In Issue | |||||
|---|---|---|---|---|---|---|---|
| Number | £ | Number | £ | Number | £ | ||
| Ordinary Shares of 0.1p each | |||||||
| Balance at 1 April 2024 | 102,067,144 | 102,067 | (18,744,491) | (18,744) | 83,322,653 | 83,323 | |
| Balance at 30 September 2024 | 102,067,144 | 102,067 | (18,744,491) | (18,744) | 83,322,653 | 83,323 | |
| B Shares of 0.1p each | |||||||
| Balance at 1 April 2024 | 32,076,703 | 32,077 | (1,367,953) | (1,368) | 30,708,750 | 30,709 | |
| Repurchased to be held in treasury | – | – | (250,000) | (250) | (250,000) | (250) | |
| Balance at 30 September 2024 | 32,076,703 | 32,077 | (1,617,953) | (1,618) | 30,458,750 | 30,459 | |
| Total at 30 September 2024 | 134,143,847 | 134,144 | (20,362,444) | (20,362) | 113,781,403 | 113,782 |
During the period the Company bought back nil Ordinary shares and bought back 250,000 B shares at a cost of £216,000 to hold in treasury (period to 30 September 2023: 1,750,000 Ordinary shares and nil B shares; year to 31 March 2024: 1,750,000 Ordinary shares and nil B shares).
At 30 September 2024 the Company held 18,744,491 Ordinary shares and 1,617,953 B shares in treasury (30 September 2023 – 18,744,491 Ordinary shares and 1,367,953 B shares; 31 March 2024 – 18,744,491 Ordinary shares and 1,367,953 B shares).
The Company's financial risk management objectives and policies are consistent with those disclosed in the Company's financial statements for the year ended 31 March 2024.
| Six months to | Six months to | Year to | |
|---|---|---|---|
| 30 September | 30 September | 31 March | |
| 2024 | 2023 | 2024 | |
| £'000 | £'000 | £'000 | |
| Opening net debt at beginning of period/year | 15,000 | 12,000 | 12,000 |
| Cash flows: | |||
| Drawdown of revolving credit facility | – | 3,000 | 3,000 |
| Closing net debt at end of period/year | 15,000 | 15,000 | 15,000 |
In assessing the going concern basis of accounting, the Directors have had regard to the guidance issued by the Financial Reporting Council and have undertaken a rigorous review of the Company's ability to continue as a going concern. The Board has, in particular, considered the outlook for inflation and ongoing macroeconomic and geopolitical concerns.
The Company's investment objective and policy, which is subject to regular Board monitoring processes, is designed to ensure that the Company is invested mainly in liquid, listed securities. The value of these investments exceeds the Company's liabilities by a significant margin. The Company retains title to all assets held by its custodian, and has an agreement relating to its borrowing facility with which it has complied. Cash is held only with banks approved and regularly reviewed by the Investment Manager.
As part of the going concern review, the Directors noted that a borrowing facility of a £15 million revolving credit facility is committed to the Company until 28 September 2025 and loan covenants are reviewed by the Board on a regular basis. It is expected that a new borrowing facility could be entered into when the current arrangement expires, but, if not, or should the Board decide not to renew it, any outstanding borrowings would be repaid through the use of cash and, if required, from the proceeds of the sale of the Company's investments.
The Directors believe, having assessed the principal risks and other matters, in light of the controls and review processes noted and bearing in mind the nature of the Company's business and assets and revenue and expenditure projections, that the Company has adequate resources to continue in operational existence for a period of at least twelve months from the date of approval of the financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
The Company does not have a fixed life. However, in the event that the net asset value total return performance of the Company is less than that of the FTSE All-Share Index over the relevant three year period, in accordance with the Company's articles of association, shareholders will be given the opportunity to vote on whether the Company should continue in existence, by ordinary resolution at the Company's Annual General Meeting. The current three year period for this purpose will run from 1 April 2022 to 31 March 2025.
The Directors of the Company are considered a related party. Under the FCA UK Listing Rules, the Manager is also defined as a related party. However, the existence of an independent Board of Directors demonstrates that the Company is free to pursue its own financial and operating policies and therefore under the AIC SORP, the Manager is not considered a related party for accounting purposes.
The Directors receive aggregated remuneration for services as Directors and for which there were no outstanding balances at the period end. There have been no transactions with related parties during the first six months of the current financial year that have materially affected the financial position or performance of the Company during the period and there have been no changes in the related party transactions described in the last Annual Report and Financial Statements that could do so.
As an investment company, investing primarily in listed securities, most of the Company's principal risks and uncertainties that could threaten the achievement of its objective, strategy, future performance, liquidity and solvency are maket related.
These risks, and the way in which they are managed, are described under the heading 'Principal Risks and Uncertainties and Viability Statement' within the Strategic Report in the Company's Annual Report and Financial Statements for the year ended 31 March 2024.
The principal risks identified in the Annual Report were:
The Board continues to review the key risk summary for the Company which identifies the risks that the Company is exposed to, the controls in place and the actions being taken to mitigate them. The Board has also considered the outlook for inflation and ongoing macroeconomic and geopolitical concerns.
The Board considers that the Company's principal risks and uncertainties have not changed materially since 30 May 2024, the date that the Company's Annual Report and Financial Statements was approved, and are not expected to change materially for the remainder of the Company's financial year. The Board has also considered these principal risks in relation to going concern, as set out in note 17 on page 22.
We confirm that to the best of our knowledge:
• the Half-Year Report includes a fair review of the information required by DTR 4.2.8R, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Company during that period, and any changes in the related party transactions described in the last Annual Report that could do so.
On behalf of the Board
28 November 2024
The Company uses the following APMs:
Discount/premium – the share price of an investment company is derived from buyers and sellers trading their shares on the stock market. This price is not identical to the net asset value (NAV) per share of the underlying assets less liabilities of the Company. If the share price is lower than the NAV per share, the shares are trading at a discount. This usually indicates that there are more sellers of shares than buyers. Shares trading at a price above NAV per share are deemed to be at a premium usually indicating there are more buyers of shares than sellers.
| 30 September 2024 | 31 March 2024 | ||||
|---|---|---|---|---|---|
| Ordinary shares |
B shares | Ordinary shares |
B shares | ||
| Net asset value per share | (a) | 97.90p | 97.90p | 94.51p | 94.51p |
| Share price | (b) | 89.25p | 86.00p | 84.50p | 83.50p |
| Discount (c=(b-a)/(a)) | (c) | -8.8% | -12.2% | -10.6% | -11.6% |
Gearing – represents the excess amount above shareholders' funds of total investments, expressed as a percentage of the shareholders' funds. If the amount calculated is negative, this is a 'net cash' position and no gearing.
| 30 September 2024 £'000 |
31 March 2024 £'000 |
||
|---|---|---|---|
| Investments held at fair value through profit or loss | (a) | 125,626 | 121,267 |
| Net assets | (b) | 111,392 | 107,766 |
| Gearing (c=(a/b)-1)% | (c) | 12.8% | 12.5% |
Total return – the theoretical return to shareholders calculated on a per share basis by adding dividends/ capital repayments paid in the period to the increase or decrease in the share price or NAV in the period. The dividends/capital repayments are assumed to have been re-invested in the form of shares or net assets, respectively, on the date on which the shares were quoted ex-dividend.
The effect of reinvesting these dividends/capital repayments on the respective ex-dividend dates and the NAV total returns and share price total returns are shown below.
| 30 September 2024 | 31 March 2024 | ||
|---|---|---|---|
| Ordinary shares/ B shares |
Ordinary shares/ B shares |
||
| NAV per share at start of period/year | 94.51p | 89.97p | |
| NAV per share at end of period/year | 97.90p | 94.51p | |
| Change in the period/year | +3.6% | +5.0% | |
| Impact of dividend/capital repayment reinvestment† | +3.2% | +6.8% | |
| NAV total return for the period/year | +6.8% | +11.8% |
† During the six months to 30 September 2024 dividends/capital repayments totalling 3.01p (Ordinary shares/B shares) went ex-dividend. During the year to 31 March 2024 the equivalent figures were 5.51p (Ordinary shares/B shares).
| 30 September 2024 | 31 March 2024 | |||
|---|---|---|---|---|
| Ordinary shares |
B shares | Ordinary shares |
B shares | |
| Share price per share at start of period/year | 84.50p | 83.50p | 82.00p | 84.50p |
| Share price per share at end of period/year | 89.25p | 86.00p | 84.50p | 83.50p |
| Change in the period/year | +5.6% | +3.0% | +3.0% | -1.2% |
| Impact of dividend/capital repayment reinvestment† | +3.8% | +3.7% | +7.2% | +6.7% |
| Share price total return for the period/year | +9.4% | +6.7% | +10.2% | +5.5% |
† During the six months to 30 September 2024 dividends/capital repayments totalling 3.01p (Ordinary shares/B shares) went ex-dividend. During the year to 31 March 2024 the equivalent figures were 5.51p (Ordinary shares/B shares)
Yield – The total annual dividend/capital repayment expressed as a percentage of the period end share price.
| 30 September 2024* | 31 March 2024 | ||||
|---|---|---|---|---|---|
| Ordinary shares |
B shares | Ordinary shares |
B shares | ||
| Annual dividend/capital repayment | (a) | 5.62p | 5.62p | 5.62p | 5.62p |
| Share price | (b) | 89.25p | 86.00p | 84.50p | 83.50p |
| Yield = (c=a/b) | (c) | 6.3% | 6.5% | 6.7% | 6.7% |
* Based on expected minimum annual dividend/capital repayment of 5.62p per share in respect of the year ending 31 March 2025.
Dividends on Ordinary shares and capital repayments on B shares are paid quarterly in August, November, February and May each year. Shareholders who wish to have distributions paid directly into a bank account rather than by cheque to their registered address can complete a mandate form for the purpose. Mandates may be obtained from Equiniti Limited (see back cover page for contact details) on request. Where distributions are paid directly into shareholders' bank accounts, dividend and capital repayment tax vouchers are sent directly to shareholders' registered addresses.
The Company's securities are listed on the London Stock Exchange. Prices are given daily in the Financial Times. The net asset value of the Company's shares are released to the market daily, on the working day following the calculation date. They are available, with other regulatory information through the National Storage Mechanism at data.fca.org.uk.
Communications with shareholders are mailed to the address held on the share register. In the event of a change of address or other amendment this should be notified to Equiniti Limited, under the signature of the registered holder.
TCFD information for CT UK High Income Trust PLC has been made available on the Document Library page of our website and can be found at www.ctukhighincome.co.uk.
Fraudsters use persuasive and high-pressure tactics to lure investors into scams. They may offer to sell to you shares that turn out to be worthless or non-existent, or to buy your shares at an inflated price in return for an upfront payment.
If you receive unsolicited investment advice or requests:
If you are approached by fraudsters please tell the FCA by using the share fraud reporting form at fca.org.uk/ scams where you can find out more about investment scams. You can also call the FCA Consumer Helpline on 0800 111 6768. If you have already paid money to share fraudsters you should contact Action Fraud on 0300 123 2040.
One of the most convenient ways to invest in CT UK High Income Trust PLC is through one of the Savings Plans run by Columbia Threadneedle Investments.
You can use your ISA allowance to make an annual tax efficient investment of up to £20,000 for the current tax year with a lump sum from £100 or regular savings from £25 a month. You can also transfer any existing ISAs to us whilst maintaining the tax benefits.
A tax efficient way to invest up to £9,000 per tax year for a child. Contributions start from £100 lump sum or £25 a month. JISAs or CTFs with other providers can be transferred to Columbia Threadneedle Investments.
For those aged 18-39, a LISA could help towards purchasing your first home or retirement in later life. Invest up to £4,000 for the current tax year and receive a 25% Government bonus up to £1,000 per year. Invest with a lump sum from £100 or regular savings from £25 a month.
This is a flexible way to invest in our range of Investment Trusts. There are no maximum contributions, and investments can be made from £100 lump sum or £25 a month.
This is a flexible way to save for a child in our range of Investment Trusts. There are no maximum contributions, and the plan can easily be set up under bare trust (where the child is noted as the beneficial owner) or kept in your name if you wish to retain control over the investment. Investments can be made from a £100 lump sum or £25 a month per account. You can also make additional lump sum top-ups at any time from £100 per account.
If your child already has a CTF, you can invest up to £9,000 per birthday year, from £100 lump sum or £25 a month. CTFs with other providers can be transferred to Columbia Threadneedle Investments.
*The CTF and JISA accounts are opened by parents in the child's name and they have access to the money at age 18.
Annual management charges and other charges apply according to the type of Savings Plan, these can be found on the relevant product Pre- sales Cost & Charges disclosure on our website www.ctinvest.co.uk.
ISA/LISA: £60+VAT GIA: £40+VAT JISA/JIA/CTF: £25+VAT
You can pay the annual charge from your account, or by direct debit (in addition to any annual subscription limits).
£12 per fund (reduced to £0 for deals placed through the online Columbia Threadneedle Investor Portal) for ISA/GIA/LISA/JIA and JISA. There are no dealing charges on a CTF.
Dealing charges apply when shares are bought or sold but not on the reinvestment of dividends or the investment of monthly direct debits. Government stamp duty of 0.5% also applies on the purchase of shares (where applicable).
The value of investments can go down as well as up and you may not get back your original investment. Tax benefits depend on your individual circumstances and tax allowances and rules may change. Please ensure you have read the full Terms and Conditions, Privacy Policy and relevant Key Features documents before investing. For regulatory purposes, please ensure you have read the Pre-sales Cost & Charges disclosure related to the product you are applying for, and the relevant Key Information Documents (KIDs) for the investment trusts you want to invest in, these can be found at www.ctinvest.co.uk/documents.
To open a new Columbia Threadneedle Savings Plan, apply online at www.ctinvest.co.uk Online applications are not available if you are transferring an existing Savings Plan with another provider to Columbia Threadneedle Investments, or if you are applying for a new Savings Plan in more than one name but paper applications are available at www.ctinvest.co.uk/ documents or by contacting Columbia Threadneedle Investments.
| Call: | 0345 600 3030** |
|---|---|
| (9.00am – 5.00pm, weekdays) | |
| Email: | [email protected] |
**Calls may be recorded or monitored for training and quality purposes.
| Call: | 0345 600 3030** |
|---|---|
| (9.00am – 5.00pm, weekdays) |
Email: [email protected]
By post: Columbia Threadneedle Management Limited, PO Box 11114, Chelmsford, CM99 2DG
You can also invest in the trust through online dealing platforms for private investors that offer share dealing and ISAs. Companies include: Barclays Stockbrokers, EQi, Halifax, Hargreaves Lansdown, HSBC, Interactive Investor, Lloyds Bank, The Share Centre

0345 600 3030, 9.00am – 5.00pm, weekdays, calls may be recorded or monitored for training and quality purposes.
The material relates to an investment trust and its Ordinary Shares and B Shares are traded on the main market of the London Stock Exchange.
The Investor Disclosure Document, Key Information Document (KID), latest annual or interim reports and the applicable terms & conditions are available from Columbia Threadneedle Investments Cannon Place, 78 Cannon Street, London EC4N 6AG, your financial advisor and/or on our website www.columbiathreadneedle.com. Please read the Investor Disclosure Document before taking any investment decision.
This material should not be considered as an offer, solicitation, advice or an investment recommendation. This communication is valid at the date of publication and may be subject to change without notice. Information from external sources is considered reliable but there is no guarantee as to its accuracy or completeness.
In the UK: Issued by Columbia Threadneedle Management Limited, No. 517895, registered in England and Wales and authorised and regulated in the UK by the Financial Conduct Authority. © 2024 Columbia Threadneedle Investments. WF560250 (01/24) UK. Expiration Date: 31/01/2025
A K Watkins (Chairman)(1) H M Galbraith (nee Driver)(2) S J Mitchell(3) A W Pottinger
Columbia Threadneedle Investment Business Limited 6th Floor, Quartermile 4, 7a Nightingale Way, Edinburgh EH3 9EG
Panmure Liberum Ropemaker Place 25 Ropemaker Street London EC2Y 9LY
Deloitte LLP 110 Queen Street Glasgow G1 3BX
Equiniti Aspect House Spencer Road Lancing West Sussex BN99 6DA
JPMorgan Europe Limited 25 Bank Street Canary Wharf London E14 5JP
JPMorgan Chase Bank 25 Bank Street Canary Wharf London E14 5JP
The Royal Bank of Scotland International Limited 440 Strand London WC2R 0QS
Dickson Minto LLP 16 Charlotte Square Edinburgh EH2 4DF
SC314671
Website ctukhighincome.co.uk
(1) Chairman of the Nomination Committee
(2) Chairman of the Audit Committee
(3) Chairman of the Engagement and Remuneration Committee and Senior Independent Director
Half-Year Report 30 September 2024
6th Floor, Quartermile 4, 7a Nightingale Way, Edinburgh EH3 9EG
Tel: 0131 573 8300
ctukhighincome.co.uk
* Lines open 8.30 am to 5.30 pm, Monday to Friday, excluding public holidays in England and Wales.

© 2024 Columbia Threadneedle Investments. Columbia Threadneedle Investments is the global brand name of the Columbia and Threadneedle group of companies.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.